Clinical Trial market research reports by GlobalData

• Glioblastoma Multiforme (GBM) - Competitive Landscape

  Dec 12, 2023  |  Published by: GlobalData  |  USD 3,495

  Glioblastoma Multiforme (GBM) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GBM therapeutics. More than 79,000 incident cases of GBM are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology fore ... Read More

• Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  Dec 07, 2023  |  Published by: GlobalData  |  USD 3,495

  Generalized Pustular Psoriasis (GPP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GPP therapeutics. More than 21,700 diagnosed prevalent cases of GPP are anticipated in 2023 in the 16 countries covered in GlobalData’s ... Read More

• Anal Cancer (AC) - Competitive Landscape

  Dec 06, 2023  |  Published by: GlobalData  |  USD 3,495

  Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More

• Menopausal Disorders (MD) - Competitive Landscape

  Nov 30, 2023  |  Published by: GlobalData  |  USD 3,495

  Menopausal Disorders (MD) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MD therapeutics. More than 208 million total prevalent cases of MD are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiolog ... Read More

• Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 21, 2023  |  Published by: GlobalData  |  USD 2,500

  Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More

• Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Seasonal Influenza Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, ... Read More

• Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, E ... Read More

• Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical Trial Analysis by Trial Phase, ... Read More

• Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More

• Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More

• Polymyositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Polymyositis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Polymyositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update ... Read More

• Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Down Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Down Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More

• Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End P ... Read More

• Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  Oct 31, 2023  |  Published by: GlobalData  |  USD 6,995

  Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary The report provides an in-depth assessment of the Myasthenia gravis market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D ... Read More

• X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spo ... Read More

• Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... Read More

• Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More

• Sleep Apnea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Sleep Apnea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Sleep Apnea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update pr ... Read More

• Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Cou ... Read More

• Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cystic Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More

• Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Sta ... Read More

• Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provid ... Read More

• Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Pulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, ... Read More

• Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Trial ... Read More

• Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 19, 2023  |  Published by: GlobalData  |  USD 3,495

  Lennox-Gastaut Syndrome (LGS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in LGS therapeutics. More than 89,000 total prevalent cases of LGS are anticipated in 2 ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >